Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy
Abstract Background Micafungin is a well-tolerated and effective prophylactic antifungal agent used in hematologic diseases. In this prospective trial, we evaluated the efficacy and safety of prophylactic micafungin during first induction chemotherapy in patients with acute leukemia. We also compare...
Main Authors: | Hyunkyung Park, Jeonghwan Youk, Dong-Yeop Shin, Junshik Hong, Inho Kim, Nam Joong Kim, Jeong-Ok Lee, Soo-Mee Bang, Sung-Soo Yoon, Wan Beom Park, Youngil Koh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-5557-9 |
Similar Items
-
Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01) -
Physicochemical characterization of micafungin and anidulafungin for its nebulized administration
by: Sonia Terradas-Campanario, et al.
Published: (2019-09-01) -
Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation
by: Döring Michaela, et al.
Published: (2012-10-01) -
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature
by: Kofla G, et al.
Published: (2011-04-01) -
Are we near to the end of the standard dose of micafungin?
by: Alexander Agrifoglio, et al.
Published: (2018-06-01)